Table 3.
Participants of the collaborative study.
| Melanie Morris, Lea-Ellen Hogie and Keith Mortimer, Biochemistry Section, Office of Laboratory & Scientific Services, Therapeutic Goods Administration,136 Narrabundah Lane, Symonston, Canberra ACT 2609, Australia. |
| Haibin Wang, Lei Li and Bingjie Hao, Zhejiang Hisun Pharmaceutical Co Ltd, 46 Waisha Rd. Jiaojiang, Taizhou, Zhejiang, China. |
| Meng Li and Lan wang, Division of Monoclonal Antibodies, NIFDC, No2.Tiantan Xili, Beijing, 100050, China. |
| Jaana Vesterinen, Finnish Medicines Agency, Mannerheimintie 166, P.O.Box 55,00300 Helsinki, Finland. |
| Sylvie Jorajuria and Marie-Emmanuelle Behr-Gross, European Directorate for the Quality of Medicines and HealthCare (EDQM) Council of Europe, 7 allée Kastner, CS 30026, F-67081 Strasbourg, France. |
| Jean-Claude Ourlin, ANSM, 635 Rue de la Garenne,CS 60007, 34740 Vendargues Cedex, France. |
| Michael Tovey and Christophe Lallemand, Biomonitor SAS, Villejuif Bio Park, 1 mail du Professor George Mathé, 94800 Villejuif, France. |
| Ulrike Herbrand and Kerstin Brack, Charles River Biopharmaceutical Services GmbH, Max-Planck-Str. 15A, 40699, Erkrath, Germany. |
| Shubrata Khedkar, Prabhavathy Munagala and Ranjan Chakrabarti, Biologics & Biotechnology Division, United States Pharmacopeia-India (P) Ltd, Plot No. D6 & D8, IKP Knowledge Park, Genome Valley, Shameerpet, Hyderabad, 500078, R.R. District, Telangana, India. |
| Ezra Mulugeta and Charlotta Mark, Medical Products Agency, P.O. Box 26, SE-751 03 Uppsala, Sweden. |
| Cornelius Fritsch and Ruzica Puljic, Biologics Process R&D, Novartis Pharma AG, Klybeckstrasse 141, CH-4052 Basel, Switzerland. |
| Chris Bird, Paula Dilger and Clive Metcalfe, Cytokines and Growth Factors Section, Biotherapeutics Group, NIBSC, Blanche Lane, South Mimms, Potters Bar, Herts, EN6 3QG, UK. |
| Stuart Dunn, Covance Laboratories Ltd, BioCMC, Otley Road, Harrogate HG3 1PY, UK. |
| Guoping Wu and Todd Geders, Bioassay, R&D Systems, Inc.614 McKinley Place NE, Minneapolis, MN 55413,USA. |
| Yong Suk Yang and Gye Mee Jang, QC C&I, Celltrion Plant 2, 20, Academy-ro 51, Yeonsugu, Incheon, 22014, Korea. |
| Jia-Ming Yang and Yucai Peng, ADQC Department, Livzon Mabpharm Inc., No.38 Chuangye North Road, Jinwan District, Zhuhai City, Guangdong Province, 519045, China. |
| Hiroko Shibata, Masato Kiyoshi, Akiko Ishii-Watabe, Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 1–18-1, Kamiyoga, Setagaya-ku, Tokyo 158–8501, Japan. |
| Yeonjoo Hong, Bioassay Group 1, QE, Samsung Bioepis, 107, Cheomdan-daero, Yeonsu-gu, Incheon, 406–840, Korea. |
| Omer Dushek, Marcus Bridge and John Nguyen, Molecular Immunology Group, Sir William Dunn School of Pathology, South Parks Road, Oxford, OX1 3RE, UK. |
| Chaomei Lin, Joseph Albanese and Ton Geurts, Janssen Biologics BV, Einsteinweg 101, 2333 CB Leiden, The Netherlands. |
| James Kessels and Raf Berghmans, apDia bvba, Raadsherenstraat 3, 2300 Turnhout, Belgium. |
| Annick de Vries and Tom Lourens, Biologicals Laboratory, Sanquin Diagnostic Services, Plesmanlaan 125, 1066CX Amsterdam, The Netherlands. |
| Daniel Nagore and Susana Catarino, Progenika Biopharma S.A., Parque Tecnológico Bizkaia, Ed. 504, 48160 Derio, Spain. |
| Melissa Snyder and Maria Willrich, Division of Clinical Biochemistry and Immunology, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. |
| Zehra Arkir, Viapath, Reference Chemistry, Biochemical Sciences, 5th Floor, North Wing, St Thomas' Hospital, SE1 7EH, UK. |
| Ermis Parussini and Simon Daviere, Theradiag, 14 Rue Ambroise Croizat, 77183 Croissy Beaubourg, France. |